VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 335 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2017. The put-call ratio across all filers is 1.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $17,000 | -71.7% | 1,000 | -81.6% | 0.00% | -100.0% |
| Q1 2017 | $60,000 | +9.1% | 5,446 | +41.3% | 0.00% | 0.0% |
| Q4 2016 | $55,000 | -62.3% | 3,855 | -35.5% | 0.00% | -75.0% |
| Q3 2016 | $146,000 | +50.5% | 5,980 | +22.6% | 0.00% | +33.3% |
| Q2 2016 | $97,000 | -1.0% | 4,877 | +30.0% | 0.00% | 0.0% |
| Q1 2016 | $98,000 | -39.1% | 3,752 | +135.7% | 0.00% | -40.0% |
| Q4 2015 | $161,000 | -97.3% | 1,592 | -95.2% | 0.01% | -97.6% |
| Q3 2015 | $5,942,000 | -20.3% | 33,318 | -0.7% | 0.21% | -15.1% |
| Q2 2015 | $7,452,000 | +8.4% | 33,552 | -3.1% | 0.24% | +8.4% |
| Q1 2015 | $6,876,000 | +38.9% | 34,630 | +0.1% | 0.23% | +39.5% |
| Q4 2014 | $4,951,000 | +13.1% | 34,609 | +3.7% | 0.16% | +9.5% |
| Q3 2014 | $4,379,000 | +1.8% | 33,388 | -2.1% | 0.15% | +1.4% |
| Q2 2014 | $4,300,000 | -3.9% | 34,118 | +0.4% | 0.15% | -8.8% |
| Q1 2014 | $4,476,000 | +10.6% | 33,976 | -1.5% | 0.16% | +6.0% |
| Q4 2013 | $4,047,000 | +13.6% | 34,490 | +1.0% | 0.15% | -5.6% |
| Q3 2013 | $3,561,000 | +23.8% | 34,151 | +2.1% | 0.16% | +15.1% |
| Q2 2013 | $2,877,000 | – | 33,443 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |